Please login to the form below

Not currently logged in
Email:
Password:

empagliflozin

This page shows the latest empagliflozin news and features for those working in and with pharma, biotech and healthcare.

With Spiriva under pressure, Boehringer moves to bolster pipeline

With Spiriva under pressure, Boehringer moves to bolster pipeline

despite solid growth for diabetes drug Jardiance (empagliflozin)   and idiopathic pulmonary fibrosis (IPF) treatment Ofev (nintedanib).

Latest news

More from news
Approximately 15 fully matching, plus 63 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics